Last update 21 Nov 2024
Redasemtide
Last update 21 Nov 2024
Overview
Basic Info
Drug Type Synthetic peptide |
Synonyms |
Target- |
Mechanism Stem cells modulators |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Gene Sequence
Sequence Code 9562349
Source: *****
Related
9
Clinical Trials associated with RedasemtideParallel-group, placebo-controlled study to evaluate the safety, tolerability, and efficacy of repeated intravenous administration of S-005151 to patients with ischemic cardiomyopathy undergoing coronary artery bypass surgery (Phase I/II)
一项在不适合使用组织型纤溶酶原激活剂或进行血栓切除术的急性缺血性卒中成人受试者中研究 redasemtide (S-005151) 相较于安慰剂的疗效和安全性的 IIb 期、多国、随机、双盲研究
[Translation] A Phase IIb, multinational, randomized, double-blind study investigating the efficacy and safety of redasemtide (S-005151) versus placebo in adult subjects with acute ischemic stroke who are not candidates for tissue plasminogen activator or thrombectomy
A Phase 2b, Multinational, Randomized, Double-blind Study to Investigate the Efficacy and Safety of Redasemtide (S-005151) Compared With Placebo in Adult Participants With Acute Ischemic Stroke Who Are Not Eligible for Tissue Pasminogen Activator or Thrombectomy
100 Clinical Results associated with Redasemtide
Login to view more data
100 Translational Medicine associated with Redasemtide
Login to view more data
100 Patents (Medical) associated with Redasemtide
Login to view more data
100 Deals associated with Redasemtide
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Acute Ischemic Stroke | Phase 2 | RS | 27 Jul 2023 | |
| Acute Ischemic Stroke | Phase 2 | GB | 27 Jul 2023 | |
| Acute Ischemic Stroke | Phase 2 | FI | 27 Jul 2023 | |
| Acute Ischemic Stroke | Phase 2 | ES | 27 Jul 2023 | |
| Acute Ischemic Stroke | Phase 2 | DE | 27 Jul 2023 | |
| Acute Ischemic Stroke | Phase 2 | CZ | 27 Jul 2023 | |
| Acute Ischemic Stroke | Phase 2 | CZ | 27 Jul 2023 | |
| Acute Ischemic Stroke | Phase 2 | KR | 27 Jul 2023 | |
| Acute Ischemic Stroke | Phase 2 | HU | 27 Jul 2023 | |
| Acute Ischemic Stroke | Phase 2 | JP | 27 Jul 2023 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free